483
Terry O'reilly, M.D.Terry O'reilly, M.D. – FDA 483, Aug 22, 2013
Record Details
An FDA inspection of Terry O'Reilly, M.D., a clinical research facility in Tempe, AZ, revealed a significant issue regarding the conduct of an investigation. The firm failed to adhere to the signed statement of investigator and investigational plan, specifically by enrolling and dosing subjects who met exclusion criteria. This indicates a failure to follow study protocols, which is a serious concern in clinical research.
View Company Profile
ID · 07a20597-147f-47af-a90f-1a9f6598d5c1
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.